| Date | Event | Source |
|---|---|---|
| 2019-03-22 | Family medicine visit: 44-year-old woman with 6-month history of widespread muscle pain, fatigue, and unrefreshing sleep. Tender points in neck, shoulders, low back, and knees on exam. Basic labs (CBC, ESR, CRP, TSH) normal. Provisional diagnosis of fibromyalgia; advised on graded exercise. | family medicine note |
| 2019-11-18 | Rheumatology consultation: 18 tender points documented; inflammatory markers and autoimmune panel unremarkable. Diagnosis confirmed: fibromyalgia. Recommends cognitive behavioral therapy, low-impact aerobic activity, and amitriptyline for sleep. | rheumatology consult note |
| 2020-05-12 | Psychiatry assessment: low mood, anhedonia, poor concentration, initial PHQ-9 score 19. Diagnosis: major depressive disorder, recurrent. Prescribed sertraline. Also notes cognitive complaints (‘brain fog’) impacting work performance. | psychiatry initial assessment |
| 2021-01-20 | Failed sertraline trial due to lack of response; switched to venlafaxine XR. Mental status exam unchanged: flat affect, slowed thought process. | psychiatry follow-up note |
| 2022-03-10 | Family medicine visit: patient reports escalating pain, severe insomnia, and profound fatigue. Requests reduced work schedule. Physician documents impaired sustained attention during interview. Continues venlafaxine, adds trazodone for sleep. | family medicine progress note |
| 2022-09-15 | Last day worked as an office administrator. Patient states she is unable to meet cognitive and sedentary demands despite ergonomic adjustments. Short-term disability application initiated. | employer disability form |
| 2023-01-15 | Long-term disability insurer approves claim under ‘own occupation’ definition, citing functional limitations from fibromyalgia and depression. Payments commence. | insurer approval letter |
| 2024-07-20 | Independent medical examination (psychiatry): reviewer opines no objective cognitive impairment, pain behaviors out of proportion, no psychosis or suicidal ideation. Concludes ‘capable of sedentary work from a psychiatric perspective’. | insurer IME report |
| 2024-08-10 | Functional capacity evaluation: findings include reduced tolerance for static sitting, frequent postural shifting, and decreased sustained concentration during clerical tasks. Examiner notes inconsistency between observed effort and some pain-limited tests but confirms limitations in prolonged attention and endurance. | FCE report |
| 2024-09-01 | Insurer denial letter: benefits terminated effective at 24-month mark, citing ‘any occupation’ definition and stating ‘no objective findings of total disability’. No further payments approved. | LTD denial letter |
The medical records consistently document functionally limiting fibromyalgia and major depressive disorder that, taken together, preclude the claimant from performing her own occupation or any other gainful employment, despite the absence of objective laboratory or imaging abnormalities.
Fibromyalgia is a recognized clinical syndrome diagnosed through validated criteria (widespread pain index, symptom severity, tender points) and is characterized by the absence of objective biomarker abnormalities. The diagnosis was appropriately confirmed by a rheumatologist after excluding inflammatory or endocrine disorders. Major depressive disorder with cognitive dysfunction (‘brain fog’) has been longitudinally documented by psychiatry, with two failed adequate medication trials indicating treatment-refractory illness. The combination results in severe, persistent functional impairment as noted by the treating family physician and reflected in the FCE’s findings of limited sitting tolerance and reduced sustained concentration.
The insurer’s reliance on ‘no objective findings’ is misplaced in the context of these conditions, which are inherently defined by subjective symptoms and functional impact. Objective findings are not required to diagnose fibromyalgia or MDD, nor to assess disability. The IME’s conclusion that the claimant is capable of sedentary work overlooks the documented concentration deficits, only briefly acknowledges the FCE, and fails to integrate the psychiatric history of cognitive slowing. While effort variability on the FCE warrants consideration, it does not negate the consistent, multi-source evidence of functional decline over three years. In total, the records support that Ms. S.B. cannot sustain the attention, stamina, and reliability needed for any full-time occupation, even sedentary.
The prognosis for full occupational recovery is poor. Fibromyalgia and recurrent MDD are chronic, often waxing and waning, but treatment-refractory depression and long-standing sleep disorder reduce the likelihood of meaningful improvement. While some symptom fluctuation may occur, resumption of competitive employment is unlikely within the foreseeable future. She remains at risk for worsening if placed under vocational stress.
She will require ongoing multidisciplinary care: psychiatry follow-up for further medication trials (e.g., augmentation with aripiprazole or bupropion), cognitive behavioral therapy for pain and mood, and a gentle graded exercise program supervised by a physiotherapist. Sleep hygiene and pharmacotherapy for insomnia need optimization. Vocational rehabilitation is not currently recommended unless there is substantial improvement in mood and stamina, which is improbable over the next 12–24 months. A home-based self-management approach may preserve limited daily function.